" /> Vacc-4x - CISMeF





Preferred Label : Vacc-4x;

MeSH note : immunotherapy candidate composed of four modified peptides corresponding to conserved domains of the HIV-1 protein p24 that preferentially include HLA-A2 restricted elements;

Is substance : O;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.